BTK inhibitors: toxicity, resistance, and combinations
Steven T. Rosen
Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.
Myeloma highlights from ASCO 2017
Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
CLL update from ICML17: Current treatment and future directions for patients